Center for suicide research and prevention - suicide is one of the leading causes of death worldwide and the 10TH leading cause of death in the US

Active Project Grant Awarded Last action

Award ID
P50MH129699
Recipient
Awarding agency
Obligated
$20,319,422

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 67% complete
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

Description

A major barrier to suicide prevention has been that the cutting-edge scientific advances that have occurred in the past few decades have not yet been translated and implemented into clinical practice settings. We propose the development of a practice-based center for suicide research and prevention (csrp) that will support the development, deployment, and evaluation of practice-ready and deployment-focused interventions aimed at improving the identification and effective treatment of those at risk of suicide. This center will be a collaborative effort between researchers, clinicians, and stakeholders at mass general brigham (MGB) and harvard university. Our focus is on improving the identification and prevention of suicide-related behaviors (srbs) among patients presenting for treatment at emergency departments (EDS) and psychiatric inpatient units. Decades of research have shown that 50% of people who DIE by suicide are seen in a healthcare setting within one month before their death, 40% visit an ED the year before their death, and the suicide rate is highest in the weeks immediately following discharge from a psychiatric inpatient hospitalization. Our first aim is to build and maintain a cohesive and innovative transdisciplinary center dedicated to advancing suicide prevention. This will be accomplished via the work of our proposed administrative core and methods core. Our second aim is to conduct four practice-focused research projects that target prediction and prevention of suicidal behaviors in ED and inpatient settings. Our signature project (SIG) will implement a previously-develop machine learning prediction algorithm based on electronic health record (EHR) and self-report data collected in the ED and randomly assign the clinicians of 4,000 patients to receive (experimental condition) or not receive (control condition) the predicted probability that their patient will make a suicide attempt after ED discharge. We will test the impact of this intervention on the suicide attempt rate and clinician decision-making. The SIG also will examine clinician acceptability and adherence, prediction model improvement, and the development of treatment optimization rules regarding patients' likelihood of benefiting from hospitalization versus alternative treatments. Our three exploratory projects (EXP): (EXP1) will use the SIG prediction model to identify ED patients at risk of suicidal behavior and experimentally test the effectiveness of an enhanced outreach intervention administered in collaboration with a community partner - samaritans of boston; (EXP2) will implement and test EHR-based risk algorithms in two inpatient units with a special focus on the use of social determinants of health to improve prediction among under-represented adolescents; and (EXP3) will test a just-in-time adaptive intervention using an innovative micro-randomized trial design to connect at-risk patients with care when needed most. The third aim of the center is to support education, dissemination, and implementation efforts that will have a significant and sustained effect on suicide prevention.

Transactions

Action Obligated Date
Amendment $3,248,400
Amendment $0
Amendment $0
Amendment $3,293,893
Amendment $3,342,450
Amendment -$145,753
Amendment -$145,753
Amendment -$12,177
Amendment -$12,177
Amendment -$12,177
Amendment $3,587,572
Amendment $3,587,572
Original award $3,587,572
Show all 13

Subawards

Subrecipient Amount Awarded
The Mclean Hospital Corporation Suicide claims over 49,000 lives annually in the United States, yet clinicians lack objective biomarkers to guide acute risk assessment. This pilot study… $82,000
Brigham & Womens Hospital Inc. Identifying suicide risk in adolescents remains difficult, especially when warning signs are subtle or not yet visible in clinical settings. This pilot… $82,492
Cambridge Public Health Commission This research plan proposes to, over the course of the CSRP Scholars Program, adapt Brief Cognitive Behavior Therapy for suicide prevention to an adolescent… $54,000
University Of Illinois The overall goal of this proposal is to develop a practice-based suicide prevention research center that aims to generate clinical innovations for suicide… $90,071
The Children's Hospital Corporation The overall goal of this proposal is to develop a center focused on practice-based suicide prevention research that aims to generate and implement clinical… $79,593
Regents Of The University Of Michigan Dr. Dempsey’s primary roles and responsibilities as a PI on this project will be to oversee the design and analysis of the micro-randomization trial.… $168,968
Cambridge Public Health Commission Dr. Carson will share authority and responsibility with Dr. Richard Liu of the Mass General Brigham (MGB; multiple PI), for leading, directing and overseeing… $365,452
President And Fellows Of Harvard College The DBMI team members participate the P50 projects as part of the methodology core, with specific deliverables on developing suicide risk prediction… $1,323,413
President And Fellows Of Harvard College Matthew Nock, PhD, is the Edgar Pierce Professor of Psychology at Harvard University. Nock has extensive experience in the oversight, design, and implementation… $1,120,210
Cambridge Public Health Commission Nick Carson, MD, is the Medical Director of the Cambridge Health Alliance (CHA) Outpatient Child and Adolescent Psychiatry Services, an Assistant Professor of… $222,624
President And Fellows Of Harvard College Ronald Kessler, PhD, is the McNeil Family Professor of Health Care Policy at HMS and an experienced psychiatric epidemiologist. As Co-Investigator of the HMS… $1,117,618
President And Fellows Of Harvard College Matthew Nock, PhD, is the Edgar Pierce Professor of Psychology at Harvard University. Nock has extensive experience in the oversight, design, and implementation… $1,164,419
Show all 12

Quick answers

Who received award P50MH129699?

P50MH129699 was awarded to The General Hospital Corporation by National Institute of Mental Health (National Institutes of Health) on August 8, 2023.

How much is award P50MH129699 worth?

$20,319,422 has been obligated on P50MH129699.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award